The frustrating reality of treating nail fungus
Most people who have dealt with nail fungus know the feeling: months of treatment, little visible progress, and growing uncertainty about whether the product is actually doing anything. That experience is common, and it is rarely the patient's fault.
Nail fungus, or onychomycosis, is one of the most prevalent fungal infections globally. Studies estimate that it affects between 5% and 14% of the global population, with rates increasing among older adults. Given how widespread the condition is, treatment success rates with conventional options remain surprisingly modest.
This article explores the structural reasons behind that, and what a 2025 clinical study reveals about an approach with stronger outcomes.
Understanding why the nail makes treatment difficult
The toenail is a dense, layered keratin structure with very limited blood supply in its distal parts. Fungal infections take hold between the nail plate and the nail bed, spreading gradually and steadily. By the time visible symptoms appear, including discolouration, thickening, and crumbling edges, the infection is often already well-established beneath the surface.
The fungus feeds on keratin, thrives in warm and moist conditions, and sits in a location that is genuinely difficult to reach with most topical formulations. Recurrence after treatment is a well-documented challenge for the same reason: the environment that allowed the infection to develop remains unchanged.
This is the underlying challenge every treatment needs to solve.
Where conventional OTC options run into trouble
Walk through any pharmacy and you will find a range of products for nail fungus. Most fall into a few familiar categories, each with its own documented limitations.
Nail lacquers and antifungal varnishes
These are applied like nail polish, forming a thin film over the nail surface. The idea is straightforward: place the active ingredient close to where the fungus lives.
Getting through the full thickness of a nail is a significant challenge, especially when the nail has thickened due to infection. Research into topical antifungal nail lacquers consistently shows modest efficacy rates, with mycological cure rates often well below 50% in controlled trials.
Usability is another factor that limits results. Lacquers typically require weekly filing of the nail surface, careful cleaning before every application, and avoidance of regular nail polish throughout the treatment period. For a condition requiring months of consistent use, that kind of routine creates real friction.
Oral antifungal tablets
Oral treatments such as terbinafine or itraconazole travel through the bloodstream to reach the nail from within. They are generally considered effective in clinical settings, but they carry a safety profile that limits their accessibility.
Systemic antifungals can interact with other medications and place strain on the liver. The NHS notes that for people taking terbinafine tablets over a longer period, a doctor may request a blood test to check liver function, and terbinafine is listed among medications associated with hepatotoxic risk. This level of medical involvement makes oral treatments a less practical choice for many patients seeking a self-managed first step.
Treatment courses also run three to six months, and recurrence after completing the course remains a documented concern.
Products without clinical evidence
This is arguably the largest category: products marketed for nail fungus that have never been evaluated in a properly structured clinical study. Ingredients vary widely, from tea tree oil to vinegar to various proprietary blends, with highly variable evidence behind them.
Without clinical data, there is no reliable way to assess what these products actually do over a sustained treatment period. Consumer reviews and before-and-after photographs cannot replace a controlled evaluation using validated scoring tools.
What a genuinely effective treatment needs to achieve
Looking at how nail fungus behaves and where treatments tend to fall short, a few requirements become clear for any product that aims to deliver consistent results.
Delivery to the infection site. The active ingredients need to reach the nail bed, going beyond surface-level application.
A safety profile suited to long-term use. Treatment for nail fungus is measured in months. Systemic risks that require medical monitoring make a product harder to use independently over that period.
Ease of daily use. Treatment adherence, meaning consistent use of the product as directed, is one of the strongest predictors of outcome in dermatological conditions. When a routine requires multiple preparatory steps or significant time, adherence drops. Lower adherence leads directly to incomplete treatment and a higher chance of recurrence.
Clinical evaluation with validated outcomes. A properly structured study, using recognised measurement tools and including independent professional assessment, is the most reliable basis for any claim about effectiveness.
What the 2025 FunghiClear clinical evaluation found
In 2025, FunghiClear, a natural nail fungus spray, completed a clinical evaluation study. The study ran for 12 weeks with 192 participants.
The results were measured across several independent dimensions.
Objective clinical improvement
67% of participants (129 out of 192) showed a measurable improvement in their Onychomycosis Severity Index (OSI) score. The OSI is a validated clinical tool used to quantify the extent and severity of nail fungal infection.
Among those who improved, the mean OSI score decreased by 44%, representing an 8.82-point reduction in severity. The Toenail Rating, a separate staging measure, improved by an average of 0.96 stages in the same group, also a 44% improvement.
Patient-reported outcomes
74% of participants reported that their toenail felt better or much better compared to the start of the study. Patient perception is an important dimension of treatment success, reflecting whether the improvement translates into something people actually notice and feel.
Independent professional assessment
73% of footcare professionals, assessing participants independently, reported visible improvement in the toenail. This third-party evaluation sits alongside patient self-reporting and objective scoring to give a fuller picture of what the treatment actually delivered.
Safety
191 out of 192 participants (99.5%) reported no pain or discomfort at the site of application. No serious adverse events were recorded across the entire study.
Usability scores
Participants rated their experience using FunghiClear throughout the 12 weeks:
-
Convenience of the upside-down spray bottle: 4.4 out of 5
-
Ability to comply with twice-daily use: 4.5 out of 5
-
Overall user experience: 4.5 out of 5
These figures reflect how the product performed in the context of real daily routines over an extended period.
Why usability data matters as much as efficacy data
In dermatology, treatment adherence is a well-documented determinant of clinical outcomes. Research published in the Journal of Dermatological Treatment identifies non-adherence as one of the leading causes of treatment failure in dermatology, with treatment complexity and duration among the key factors driving patients to stop using a product before the course is complete.
A spray that requires no filing, no waiting time, and no multi-step preparation removes the kinds of friction that cause people to stop using other formats before the treatment is complete. The usability scores from the FunghiClear study (4.4 to 4.5 out of 5) indicate that participants found the format genuinely manageable across 12 weeks of twice-daily use.
A note for distributors and footcare professionals
Patients who arrive having already tried multiple products are common in footcare and pharmacy settings. They are often uncertain about what to try next, and sometimes sceptical that anything will deliver a meaningful difference.
A product with published clinical data, a clean safety record, and high patient-reported usability gives practitioners something concrete to point to. The conversation shifts from general guidance to specific, documented evidence.
Ready to try something with clinical backing?
FunghiClear is natural, clinically evaluated in a recent study with 192 participants, and designed to make twice-daily treatment straightforward. The upside-down spray mechanism delivers directly to the nail bed, and patients in the study rated both the convenience and their ability to stick with it at 4.5 out of 5.
Try FunghiClear and see the results for yourself.
Frequently asked questions about nail fungus treatment
What is the most effective treatment for nail fungus?
Effectiveness depends on the severity of the infection, the patient's overall health profile, and how consistently the treatment is used over time. Clinical evaluation studies offer the most reliable evidence. A 2025 study of FunghiClear found that 67% of participants showed measurable OSI score improvement after 12 weeks of use.
How long does nail fungus treatment take?
Treatment typically takes several months regardless of the product. Nails grow slowly, and the infection clears as new, healthy nail replaces infected tissue. Consistent daily use throughout the full treatment period is essential for results.
Are natural nail fungus treatments clinically effective?
The answer depends on whether the specific product has been evaluated in a structured clinical setting using validated scoring tools and independent professional assessment. FunghiClear is one of very few natural nail fungus products to have published clinical evaluation data from a 192-participant study.
Why does nail fungus keep coming back after treatment?
Recurrence happens for several reasons: incomplete treatment, reinfection from the environment (footwear, socks, shared surfaces), or an underlying susceptibility to fungal infections. Completing the full treatment course and taking preventative steps afterwards significantly reduces the likelihood of recurrence.
Is a spray format better than a nail lacquer for treating nail fungus?
Spray formats can offer meaningful advantages in delivery, particularly when the application mechanism allows for targeted contact with the nail bed rather than the nail surface only. Adherence data also tends to be stronger for spray formats because the routine requires fewer preparation steps. In the FunghiClear study, participants rated their ability to comply with twice-daily use at 4.5 out of 5.
Can footcare professionals recommend FunghiClear?
Yes. The 2025 clinical evaluation included independent assessment by footcare professionals, 73% of whom reported visible improvement in participants' toenails. Full study information is available for professional review here.
This article is for informational purposes. Individual results may vary. For persistent or severe nail conditions, consulting a healthcare professional is recommended.